1,183.46 USD
↗ 1.57 (0.13%)AT CLOSE (11:59 AM EDT)
Eli Lilly & Co.
LLYNYSE • USD
1,183.81
↗ 0.35 (0.03%)
POST MARKET (AS OF 08:14 PM EDT)
Post Market
AS OF 08:14 PM EDT
1,183.81
↗ 0.35 (0.03%)
Market: CLOSED
Shares of Eli Lilly & Co. (LLY) are trading at $1,183.46. Both sides of the analysis agree: technicals flash "Strong Buy" and fundamentals confirm with a "Buy" reading. This is driven by a robust Altman Z-Score, exceptional Return on Equity (78.8%) and a bullish Golden Cross on the moving averages. On the valuation front, LLY trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Sep 25, 2026.
Open?$1,185.32
High?$1,190.00
Low?$1,160.84
Prev. Close?$1,181.89
Volume?1.9M
Avg. Volume?2.4M
VWAP?$1,174.29
Rel. Volume?0.79x
Bid / Ask
Bid?$1,183.74 × 120
Ask?$1,183.87 × 160
Spread?$0.13
Midpoint?$1,183.80
Valuation & Ratios
Market Cap?1054.9B
Shares Out?941.4M
Float?849.7M
Float %?90.3%
P/E Ratio?39.49
P/B Ratio?31.14
EPS?$29.97
Dividend?0.55%
Ex-Dividend?N/A
News
Profile
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Themes
Employees
50.0K
Market Cap
1054.9B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1970-07-09
Address
LILLY CORPORATE CTR
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?100
Momentum?60
Short Sent.?57
Piotroski F-Score?6/9Mixed
Altman Z-Score?7.64Safe
Confidence?72%Moderate
Short InterestModerate
Short % of Float?0.89%Low
Short Interest?7.5M
Days to Cover?3.4
Free Float849.7M
Avg Daily Volume2.2M
Settlement Date2026-09-15
Financial Health
Current Ratio?1.35Adequate
Quick Ratio?1.00Adequate
Cash Ratio?0.19Low
Debt/Equity?1.62High
ValuationRICHLY VALUEDvs 10 peers + S&P 500
Score33/100
P/E?39.5PRICEY▾
Peers40
S&P18
P/B?31.14HIGH▾
Peers10
S&P3
P/S?13.24HIGH▾
Peers20
S&P3
P/FCF?58.0PRICEY▾
Peers10
S&P8
EV/EBITDA?26.4HIGH▾
Peers30
S&P14
EV/Sales?13.82HIGH▾
Peers20
S&P3
Returns & Efficiency
ROE?78.8%STRONG▾
Peers89
S&P97
ROA?18.8%STRONG▾
Peers80
S&P93
Cash Flow & Enterprise
FCF?$18.2B
Enterprise Value?$1100.8B
Fundamentals ratios updated end of day